355 related articles for article (PubMed ID: 18511546)
1. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study.
Vonk MC; Broers B; Heijdra YF; Ton E; Snijder R; van Dijk AP; van Laar JM; Bootsma H; van Hal PT; van den Hoogen FH; van Daele PL
Ann Rheum Dis; 2009 Jun; 68(6):961-5. PubMed ID: 18511546
[TBL] [Abstract][Full Text] [Related]
2. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
Wigley FM; Lima JA; Mayes M; McLain D; Chapin JL; Ward-Able C
Arthritis Rheum; 2005 Jul; 52(7):2125-32. PubMed ID: 15986394
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis.
Phung S; Strange G; Chung LP; Leong J; Dalton B; Roddy J; Deague J; Playford D; Musk M; Gabbay E
Intern Med J; 2009 Oct; 39(10):682-91. PubMed ID: 19220532
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.
Kuo CF; See LC; Yu KH; Chou IJ; Tseng WY; Chang HC; Shen YM; Luo SF
Scand J Rheumatol; 2011; 40(5):373-8. PubMed ID: 21388247
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
Steen VD; Lucas M; Fertig N; Medsger TA
J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002.
Alamanos Y; Tsifetaki N; Voulgari PV; Siozos C; Tsamandouraki K; Alexiou GA; Drosos AA
Semin Arthritis Rheum; 2005 Apr; 34(5):714-20. PubMed ID: 15846586
[TBL] [Abstract][Full Text] [Related]
8. [Causes of death of patients with systemic sclerosis].
Chwieśko S; Sierakowski S; Kowal-Bielecka O
Pol Merkur Lekarski; 2006 Oct; 21(124):341-4. PubMed ID: 17205772
[TBL] [Abstract][Full Text] [Related]
9. A study of the prevalence of systemic sclerosis in northeast England.
Allcock RJ; Forrest I; Corris PA; Crook PR; Griffiths ID
Rheumatology (Oxford); 2004 May; 43(5):596-602. PubMed ID: 14872101
[TBL] [Abstract][Full Text] [Related]
10. Determinants of pulmonary arterial hypertension in scleroderma.
Plastiras SC; Karadimitrakis SP; Kampolis C; Moutsopoulos HM; Tzelepis GE
Semin Arthritis Rheum; 2007 Jun; 36(6):392-6. PubMed ID: 17204309
[TBL] [Abstract][Full Text] [Related]
11. The occurrence of pulmonary hypertension in patients with systemic sclerosis hospitalized in the Department of Rheumatology and Internal Diseases Medical University of Białystok in years 2003-2004.
Gińdzieńska-Sieśkiewicz E; Kowal-Bielecka O; Kita J; Lisowska A; Domysławska I; Musiał W; Sierakowski S
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():297-300. PubMed ID: 16119691
[TBL] [Abstract][Full Text] [Related]
12. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA
Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
[TBL] [Abstract][Full Text] [Related]
14. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
Hofstee HM; Vonk Noordegraaf A; Voskuyl AE; Dijkmans BA; Postmus PE; Smulders YM; Serné EH
Ann Rheum Dis; 2009 Feb; 68(2):191-5. PubMed ID: 18375538
[TBL] [Abstract][Full Text] [Related]
15. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
Nihtyanova SI; Tang EC; Coghlan JG; Wells AU; Black CM; Denton CP
QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
[TBL] [Abstract][Full Text] [Related]
16. Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study.
Overbeek MJ; Groepenhoff H; Voskuyl AE; Smit EF; Peeters JW; Vonk-Noordegraaf A; Spreeuwenberg MD; Dijkmans BC; Boonstra A
Respir Res; 2008 Oct; 9(1):68. PubMed ID: 18828919
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N
J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary hypertension in patients with systemic scleroderma with CREST-syndrome and without it].
Karoli NA; Rebrov AP; Orlova EE
Ter Arkh; 2004; 76(5):15-8. PubMed ID: 15230125
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary complications: one of the most challenging complications of systemic sclerosis.
Wells AU; Steen V; Valentini G
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii40-4. PubMed ID: 19487223
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
